Remove Big Data Remove Genomics Remove Medicine Remove Research
article thumbnail

Recognizing the Real People Behind the Big Data and Artificial Intelligence in Clinical Research

ACRP blog

If you hadn’t already noticed, the clinical research enterprise has well and truly entered the era of “big data,” artificial intelligence (AI), and machine learning. Undoubtedly, the expectations for precision medicine are high,” Olsen adds.

article thumbnail

The future of AI drug discovery & development in immunology and GPCR research

pharmaphorum

Alphabet subsidiary and precision health company Verily recently announced a breakthrough in its AI drug discovery GPCR research collaboration with Sosei Heptares. The companies hope that in the year to come those data targets will be entered for validation, hit generation, and lead selection. What, then, is the solution?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Digitalising drug discovery

pharmaphorum

As data and digital technology become vital to every aspect of life sciences, the industry is increasingly looking beyond biologists, chemists, and doctors to drive its drug development – and finding that technology has a chief role to play in the future of medicine. on Big data: astronomical or genomical? ,

article thumbnail

Medical Informatics: a bridge between two worlds

pharmaphorum

This is where modern technologies and data-driven medical informatics can bridge gaps in RD research. . The webinar will also cover: How the necessary routine and research data can be collected in registries in a further processable form by patients and healthcare professionals.

article thumbnail

From Wearables to AI: Digital Health Tools Are Driving Cancer Care

XTalks

Let’s explore how digital health is making significant strides in cancer care and research. RELATED: OncoHealth Expands Its Iris Platform for Digital Cancer Care Big Data and AI in Oncology Big data analytics is opening new avenues in cancer research.

article thumbnail

Takeda, Daiichi-backed wearable study planned in Japan

pharmaphorum

The results generated in the study will be combined with data from Tohoku’s Medical Megabank Project (TMM), a wide-ranging national project that is tracking the health of the Japanese population, originally set up in response to the 2011 earthquake and tsunami.

article thumbnail

Medical Informatics and Rare Disease: a bridge between two worlds

pharmaphorum

And this is where modern technologies and data-driven medical informatics can really bridge the gaps in rare disease research,” said Dr Joanne Hackett, head of Genomic and Precision Medicine at IQVIA, during a recent pharmaphorum webinar. Navigating rare disease research and treatment.

Genomics 105